Culpeper Star-Exponent: Spanberger backs measure combating fentanyl drug cocktail, ‘tranq’

Apr 20, 2023
In the News


U.S. Rep. Abigail Spanberger, D-7th, is backing a bipartisan measure to crack down on “tranq,” xylazine-adulterated fentanyl contributing to fatal overdoses across the country.

Rappahannock Rapidan Health District notified local residents the DEA recently declared the drug cocktail an emergent threat to public health.

“The Combating Illicit Xylazine Act” would address the abuse of xylazine by empowering law enforcement to go after distributors and manufacturers, and classify illicit use of the veterinary tranquilizer as a Schedule III substance.

According to the U.S. Drug Enforcement Agency, 23% of fentanyl powder examined in 2022 contained xylazine, an easily accessible and cheap cutting agent.

“Fatal drug overdoses remain the leading cause of unnatural death in Virginia,” Spanberger said in a statement.

“That’s why we need to remain vigilant about new substances that could exacerbate fentanyl’s effects and take the lives of our fellow Virginians. And right now, I’m hearing concerns about the zombie drug “tranq” from Virginia law enforcement officials, community leaders and recovery advocates.”

The cosponsored bill would empower the DEA to track xylazine manufacturing to prevent it from making it to the illicit market; require a report on prevalence, risks and recommendations to best regulate illicit use; ensure all salts and isomers of xylazine are covered when restricting illicit use; and declare xylazine an emerging drug threat, which has already been done.

“Unfortunately, we haven’t seen the worst wave of death that this powerful and highly addictive drug can bring,” said Spanberger.

“As a former federal agent and CIA case officer who worked narcotics cases and tracked dangerous cartels, I recognize how tranq presents a unique threat to our communities. This bipartisan bill would give law enforcement at all levels more tools in their toolbox to penalize drug traffickers, protect our Virginia communities, and prevent more overdose deaths.”

Legislation sponsors are U.S. Reps. Jimmy Panetta (D-CA), August Pfluger (R-TX), Gus Bilirakis (R-FL), Ken Buck (R-CO), and Chris Pappas (D-NH). In the U.S. Senate, a companion bill is led by U.S. Senators Catherine Cortez Masto (D-NV), Chuck Grassley (R-IA), and Maggie Hassan (D-NH).

Xylazine can cause depressed breathing and heart rate, unconsciousness, necrosis and even death. Because it is not an opioid, naloxone does not reverse the effects. There are currently no xylazine reversal drugs approved for humans.

Because Xylazine is not a scheduled narcotic, it is easily purchased online for as little as $6 to $20 per kilogram, according to the DEA.

Recent Posts

Jun 14, 2024

Spanberger Statement on Supreme Court Ruling to Strike Down Federal Bump Stock Ban

Congresswoman: “As a Former Federal Law Enforcement Officer, I Know that Weapons Designed to Inflict Maximum Casualties Do Not Belong on Our Streets, in Our Schools, or in Our Communities” WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today released the following statement following the U.S. Supreme Court’s decision in Garland v. Cargill, which overturns a […]

Jun 14, 2024
Gun Safety

During National Gun Violence Awareness Month, Spanberger Urges Speaker Johnson to Bring Bipartisan Bills to U.S. House Floor to Prevent Gun Violence

Congresswoman: “I Used To Carry A Gun Every Single Day — I Know What It Is To Be A Responsible Gun Owner” WASHINGTON, D.C. — On the floor of the U.S. House of Representatives, U.S. Representative Abigail Spanberger — a Member of the U.S. House Gun Violence Prevention Task Force — urged Speaker Johnson to […]

Jun 13, 2024
Womens' Issues

Spanberger Statement on Supreme Court Ruling to Protect Mifepristone Access

Congresswoman: “We Should Never Have Come This Close to the Fundamental Freedoms of Women in Virginia and Across the Country Being Stripped Away” WASHINGTON, D.C. — U.S. Representative Abigail Spanberger today released the following statement after the U.S. Supreme Court’s ruling to uphold access to mifepristone. “Since the Supreme Court overturned Roe v. Wade nearly […]